flucytosine and voriconazole

flucytosine has been researched along with voriconazole in 98 studies

Research

Studies (98)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (3.06)	18.2507
2000's	49 (50.00)	29.6817
2010's	39 (39.80)	24.3611
2020's	7 (7.14)	2.80

Authors

Authors	Studies
Abonía, R; Delgado, P; Enriz, RD; Garibotto, FM; Insuasty, B; Juárez, S; Nogueras, M; Quiroga, J; Rodero, L; Sortino, M; Zacchino, SA	1
Aurbach, U; Cornely, O; Seifert, H; Stefanik, D	1
Alvarado-Ramírez, E; Torres-Rodríguez, JM	1
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA	1
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C	1
Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA	1
Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C	1
Fritsche, TR; Jones, RN; Rhomberg, PR; Sader, HS	1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL	1
Boekhout, T; Curfs-Breuker, I; Fernández, CM; Illnait-Zaragozi, MT; Martínez, GF; Meis, JF	1
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Fothergill, AW; Patterson, TF; Thompson, GR; Vallor, AC; Wickes, BL; Wiederhold, NP	1
Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD	1
Dimopoulos, G; Falagas, ME; Velegraki, A	1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL	3
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE	1
Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA	1
Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chapeland-Leclerc, F; Girard, A; Hennequin, C; Lacroix, C; Noël, T; Papon, N; Ribaud, P; Socié, G	1
Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, RN; Marco, F; Messer, S; Pfaller, MA	1
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ	1
Jones, RN; Marco, F; Messer, SA; Pfaller, MA	1
Amariglio, N; Bielorai, B; Golan, H; Kaplinisky, C; Keller, N; Mandel, M; Neumann, Y; Paswell, J; Rechavi, G; Toren, A; Weintraub, M; Wolach, B	1
Kämmerer, R; Klempien, I; Kujath, P; Muhl, E	1
Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ	1
Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A	1
Cuenca-Estrella, M; Gómez-López, A; Monzón, A; Rodriguez-Tudela, JL	1
Ernst, EJ; Klepser, ME; Roling, EE; Yodoi, K	1
del Palacio, A; Garau, M; Pereiro, M	1
Bliss, JM; Gigliotti, F; Wellington, M	1
Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S	1
Schwartz, S; Thiel, E	1
Al-Fattani, MA; Douglas, LJ	1
Baldassarri, I; Barchiesi, F; Fothergill, AW; Maracci, M; Rinaldi, MG; Scalise, G; Spreghini, E	1
Steinbach, WJ	1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C	1
Guarro, J; Marimon, R; Mariné, M; Pastor, FJ; Serena, C	1
Chen, SC; Sorrell, TC	1
Diekema, DJ; Pfaller, MA; Procop, GW; Rinaldi, MG	1
Khakoo, RA; Khan, FA; Slain, D	1
Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW	1
Andes, D; Smith, J	1
Mercier, RC; Pai, MP; Samples, ML; Spilde, MN	1
Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A	1
Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N	1
Choi, CW; Joo, SI; Kim, BS; Kim, EC; Kim, TU; Kim, YK; Lee, KM; Lee, YS; Yoo, JI; Yun, SH	1
Maesaki, S; Tarumoto, N	1
Gerlach, U; Guckelberger, O; Jörres, D; Kohler, S; Neuhaus, P; Pascher, A; Pratschke, J; Sauer, IM	1
Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M	1
Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R	1
Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S	1
Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A	1
Borman, AM; Houbraken, J; Rijs, AJ; Samson, RA; Verweij, PE	1
Bartlett, KH; Boekhout, T; Geertsen, E; Hagen, F; Illnait-Zaragozi, MT; Klaassen, CH; Meis, JF; Swinne, D	1
Nweze, EI; Ogbonnaya, UL	1
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY	1
Click, J; Gee, SN; Hsu, MY; Rothschild, B; Saavedra, A; Sheth, V	1
Hamoud, S; Hayek, T; Keidar, Z	1
Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M	1
Kim, HR; Lee, MK; Yu, N	1
Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F	1
Su, J; Sun, W; Xu, S; Yan, D	1
Choi, HJ; Ju, MY; Jung, SI; Kim, SH; Lee, K; Lee, WG; Park, YJ; Shin, JH	1
Furuya, N; Mano, Y; Morishige, H; Oguri, T	1
Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C	1
Arakawa, S; Fujisawa, M; Osawa, K; Shigemura, K; Yoshida, H	1
Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J	1
Chang, CC; Coovadia, Y; Dorasamy, A; French, M; Lewin, S; Mahabeer, Y; Mlisana, K; Moosa, MY; Naidu, D; Ndung'u, T	1
Li, J; Liu, B; Pan, A; Zhang, L; Zhou, S	1
Frenkel, M; Lev, S; Nahmias, M; Segal, E; Semis, R	1
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA	1
He, C; Kang, M; Lei, Y; Xiao, YL; Xie, Y; Zhang, CY	1
Bulanda, M; Jagielski, T; Skóra, M	1
Chen, D; Chen, M; Dai, C; Huang, X; Li, Y; Wang, L; Wang, X; Xu, X; Yang, L; Yao, D; Yu, C; Yu, X	1
Bouchrik, M; Boumhil, L; Iken, M; Lemkhente, Z; Lmimouni, B; Naoui, H; Uwingabiye, J; Zohoun, AG	1
Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W	1
Busso-Lopes, AF; Kamei, K; Lyra, L; Mikami, Y; Moretti, ML; Peron, IH; Reichert-Lima, F; Schreiber, AZ; Taguchi, H	1
Cen, W; Feng, W; Lv, Y; Ma, Y; Qiao, Z; Wang, Y; Xi, Z; Yang, J	1
Aquino, VR; de Azevedo, MI; Goldani, LZ; Neto, GW; Pilla, C; Wirth, F	1
Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A	1
Abebaw, Y; Bitew, A	1
Almeida-Paes, R; Brito-Santos, F; Cardarelli-Leite, P; da Silva, SA; Fialho, MM; Fortes, ST; Lázera, MDS; Morales, BP; Nascimento, CR; Nishikawa, MM; Santos, LO; Santos, W; Trilles, L	1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E	1
Cheng, J; Tao, R; Xu, L; Zhao, Q; Zhu, B	1
Borman, AM; Fraser, M; Johnson, EM; Muller, J; Palmer, MD; Patterson, Z; Szekely, A; Walsh-Quantick, J	1
Pea, F	1
Dong, J; Huang, D; Liang, Z; Tang, Y; Wang, K; Wang, Y; Wen, L; Yu, H; Zhang, Y	1
Fatahinia, M; Kiasat, N; Mahmoudabadi, AZ; Moslem, M	1
Lu, F; Wang, B; Wang, Y; Xu, Y; Zhang, L; Zhang, M	1
Jiang, Y; Li, M; Liu, J; Peng, F; Su, X; Wang, A; Wang, Y; Xu, X; Yang, L	1
Chen, Y; Harypursat, V; Lan, K; Lu, Y; Wu, Y; Xu, X; Yang, T; Yu, J; Zeng, Q; Zhang, W; Zhao, T; Zhou, G	1

Reviews

10 review(s) available for flucytosine and voriconazole

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Antifungal pharmacotherapy for neonatal candidiasis. Seminars in perinatology, 2003, Volume: 27, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2003
CNS-aspergillosis: are there new treatment options? Mycoses, 2003, Volume: 46 Suppl 2 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2003
Antifungal agents in children. Pediatric clinics of North America, 2005, Volume: 52, Issue:3 Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole	2005
Antifungal agents. The Medical journal of Australia, 2007, Oct-01, Volume: 187, Issue:7 Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole	2007
Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotherapy, 2007, Volume: 27, Issue:12 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucytosine; Humans; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2007
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. Therapeutic drug monitoring, 2008, Volume: 30, Issue:2 Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole	2008
[Oral antifungal agents]. Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12 Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole	2008
Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review. BMC infectious diseases, 2015, Sep-22, Volume: 15 Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Fungemia; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pleural Effusion; Voriconazole	2015
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis. Mycoses, 2020, Volume: 63, Issue:8 Topics: Amphotericin B; Animals; Antifungal Agents; Antimicrobial Stewardship; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis, Invasive; Echinocandins; Fluconazole; Flucytosine; Humans; Species Specificity; Triazoles; Voriconazole	2020

Other Studies

88 other study(ies) available for flucytosine and voriconazole

Article	Year
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines. Bioorganic & medicinal chemistry, 2007, Jan-01, Volume: 15, Issue:1 Topics: Antifungal Agents; Computer Simulation; Drug Design; Microbial Sensitivity Tests; Microwaves; Mitosporic Fungi; Molecular Structure; Rhodanine; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Yeasts	2007
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Antifungal Agents; Area Under Curve; Candida; Fungemia; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles	2007
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole	2007
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2007
Combined therapies in a murine model of blastoschizomycosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole	2007
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment. Bioorganic & medicinal chemistry, 2008, Jan-15, Volume: 16, Issue:2 Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States	2008
In vitro antifungal susceptibilities of five species of sporothrix. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis	2008
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3 Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis; Catheterization, Central Venous; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungemia; Fungi; Humans; Microbial Sensitivity Tests	2008
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3 Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts	2008
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles	2008
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Serotyping; Triazoles; Voriconazole	2009
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae	2009
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies	2009
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain	2009
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia	2009
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles	2009
In vitro activity of thimerosal against ocular pathogenic fungi. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal	2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungal Proteins; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Microbial Sensitivity Tests; Point Mutation	2010
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans. European journal of medicinal chemistry, 2010, Volume: 45, Issue:11 Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	1998
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. Journal of clinical microbiology, 1999, Volume: 37, Issue:3 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	1999
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. Medical mycology, 1998, Volume: 36, Issue:6 Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole	1998
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bone marrow transplantation, 2000, Volume: 26, Issue:9 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Child, Preschool; Combined Modality Therapy; Drug Resistance, Microbial; Flucytosine; Granulocyte Colony-Stimulating Factor; Granulocytes; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Neutrophils; Osteomyelitis; Pyrimidines; Respiratory Burst; Ribs; Triazoles; Voriconazole	2000
[Invasive aspergillosis on a surgical intensive care unit]. Mycoses, 2000, Volume: 43 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2000
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy]. Mycoses, 2000, Volume: 43 Suppl 2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole	2000
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease. AIDS (London, England), 2001, Nov-23, Volume: 15, Issue:17 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole	2001
In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole. The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:6 Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2001
Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole	2002
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole	2003
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole	2003
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
Penetration of Candida biofilms by antifungal agents. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9 Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Colony Count, Microbial; Culture Media; Diffusion; Fluconazole; Flucytosine; Microscopy, Electron, Scanning; Mutation; Pyrimidines; Staphylococcus epidermidis; Triazoles; Voriconazole	2004
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9 Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Combinations; Drug Synergism; Flucytosine; Kinetics; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole	2004
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:3 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts	2006
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12 Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole	2006
Effect of antifungal treatment in a murine model of blastoschizomycosis. International journal of antimicrobial agents, 2007, Volume: 29, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Geotrichosis; Geotrichum; Immunocompromised Host; Immunosuppressive Agents; Kidney; Liver; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2007
Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. Journal of clinical microbiology, 2007, Volume: 45, Issue:11 Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Time Factors; Triazoles; Voriconazole	2007
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method. Canadian journal of microbiology, 2007, Volume: 53, Issue:12 Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole	2007
Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Endocarditis; Flucytosine; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Models, Biological; Pyrimidines; Triazoles; Voriconazole	2008
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole. Medical mycology, 2009, Volume: 47, Issue:2 Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2009
Five-year retrospective review of guideline-based management of fungal endophthalmitis. Acta ophthalmologica, 2008, Volume: 86, Issue:5 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole	2008
National surveillance of antifungal susceptibility of Candida species in South Korean hospitals. Medical mycology, 2009, Volume: 47, Issue:5 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Republic of Korea; Triazoles; Voriconazole	2009
Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation. Transplant international : official journal of the European Society for Organ Transplantation, 2009, Volume: 22, Issue:5 Topics: Adult; Amphotericin B; Aspergillosis; Cerebrum; Female; Flucytosine; Humans; Immunocompromised Host; Intestines; Kidney Transplantation; Lung Diseases, Fungal; Neuroaspergillosis; Pyrimidines; Sphenoid Sinus; Triazoles; Voriconazole	2009
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole	2009
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp]. Le infezioni in medicina, 2009, Volume: 17, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole	2009
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne. The new microbiologica, 2009, Volume: 32, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole	2009
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7 Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts	2010
Identification of Paecilomyces variotii in clinical samples and settings. Journal of clinical microbiology, 2010, Volume: 48, Issue:8 Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine; Fungal Proteins; Genes, rRNA; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Paecilomyces; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 5.8S; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole	2010
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Animals; Antifungal Agents; Cryptococcus gattii; Environmental Microbiology; Fluconazole; Flucytosine; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole	2010
Oral Candida isolates among HIV-infected subjects in Nigeria. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2011, Volume: 44, Issue:3 Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole	2011
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland. Mycopathologia, 2011, Volume: 172, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole	2011
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis. Archives of dermatology, 2011, Volume: 147, Issue:7 Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrosis; Pentamidine; Phosphorylcholine; Pyrimidines; Skin Diseases, Parasitic; Skin Ulcer; Sulfadoxine; Triazoles; Voriconazole	2011
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient. The Israel Medical Association journal : IMAJ, 2011, Volume: 13, Issue:9 Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole	2011
[Study on in vitro susceptibility of Candida spp. isolated from blood culture]. Le infezioni in medicina, 2012, Volume: 20, Issue:1 Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole	2012
The first Korean case of candidemia due to Candida dubliniensis. Annals of laboratory medicine, 2012, Volume: 32, Issue:3 Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheterization, Central Venous; Female; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Triazoles; Voriconazole	2012
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus. The new microbiologica, 2012, Volume: 35, Issue:3 Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole	2012
Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 12 Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cross Infection; DNA, Fungal; DNA, Intergenic; Drug Resistance, Multiple, Fungal; Female; Flucytosine; Genetic Variation; Genotype; Hemolysin Proteins; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Urinary Tract Infections; Virulence Factors; Voriconazole	2012
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea. Annals of laboratory medicine, 2012, Volume: 32, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Tertiary Care Centers; Triazoles; Voriconazole	2012
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp. The Japanese journal of antibiotics, 2012, Volume: 65, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. The Indian journal of medical research, 2012, Volume: 136, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole	2012
Candida urinary tract infection and Candida species susceptibilities to antifungal agents. The Journal of antibiotics, 2013, Volume: 66, Issue:11 Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Flucytosine; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Urinary Tract Infections; Voriconazole	2013
Antifungal susceptibility of Candida isolates at one institution. Medical mycology journal, 2014, Volume: 55, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole	2014
Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformans. Diagnostic microbiology and infectious disease, 2014, Volume: 80, Issue:4 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Fluconazole; Flucytosine; Humans; South Africa; Voriconazole	2014
Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2015, Volume: 33 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Child; Child, Preschool; China; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Infant; Itraconazole; Middle Aged; Voriconazole; Young Adult	2015
Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods. Journal de mycologie medicale, 2015, Volume: 25, Issue:1 Topics: Antifungal Agents; Aspergillus; Caspofungin; Drug Combinations; Echinocandins; Emulsions; Flucytosine; Humans; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nystatin; Phospholipids; Soybean Oil; Terbinafine; Voriconazole	2015
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012. Mycoses, 2015, Volume: 58, Issue:4 Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Candida; China; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mutation; Rhodotorula; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole	2015
[Genotypes and in vitro antifungal susceptibility of Cryptococcus isolates in Sichuan Province]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2015, Volume: 46, Issue:1 Topics: Amphotericin B; Antifungal Agents; China; Cryptococcus; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Polymorphism, Restriction Fragment Length; Voriconazole	2015
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9 Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole	2015
Comparison of two antifungal susceptibility testing of Candida sp. isolates using agar diffusion method: Neo-sensitabs® tablets and Bio-rad® disks. Journal de mycologie medicale, 2016, Volume: 26, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Immunodiffusion; Microbial Sensitivity Tests; Prospective Studies; Tablets; Voriconazole	2016
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina. Mycoses, 2016, Volume: 59, Issue:6 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole	2016
Evaluation of antifungal combination against Cryptococcus spp. Mycoses, 2016, Volume: 59, Issue:9 Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Typing; Naphthalenes; Polymorphism, Restriction Fragment Length; Terbinafine; Voriconazole	2016
Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; RNA, Messenger; Sequence Analysis, DNA; Voriconazole	2017
Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis. Medical mycology, 2018, Apr-01, Volume: 56, Issue:3 Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Child; Cryptococcus; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Intracranial Pressure; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Treatment Outcome; Voriconazole	2018
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24 Suppl 1 Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole	2018
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC women's health, 2018, 06-15, Volume: 18, Issue:1 Topics: Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Ethiopia; Female; Fluconazole; Flucytosine; Humans; Micafungin; Microbial Sensitivity Tests; Middle Aged; Prevalence; Reproductive Tract Infections; Sexual Partners; Voriconazole; Young Adult	2018
Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods. Medical mycology, 2019, Oct-01, Volume: 57, Issue:7 Topics: Amphotericin B; Antifungal Agents; Brazil; Clinical Laboratory Techniques; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Flucytosine; Humans; Microbial Sensitivity Tests; Voriconazole	2019
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Scientific reports, 2019, 03-07, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult	2019
An AIDS patient with urine retention. BMC infectious diseases, 2019, Dec-12, Volume: 19, Issue:1 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; China; Cryptococcosis; Cryptococcus neoformans; Delayed Diagnosis; Diagnostic Errors; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Prostatitis; Treatment Outcome; Urinary Retention; Voriconazole	2019
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method. The Journal of antimicrobial chemotherapy, 2020, 05-01, Volume: 75, Issue:5 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; United Kingdom; Voriconazole	2020
Crazy-paving patterns as rare radiological manifestations of pulmonary cryptococcosis: a case report. BMC pulmonary medicine, 2021, Mar-12, Volume: 21, Issue:1 Topics: Amphotericin B; Antifungal Agents; Bronchoscopy; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged; Tomography, X-Ray Computed; Voriconazole	2021
Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals. Molecular biology reports, 2021, Volume: 48, Issue:5 Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Genetic Loci; Genetic Variation; Genotype; Imidazoles; Iran; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Voriconazole	2021
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients. Clinical laboratory, 2022, Jun-01, Volume: 68, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Risk Factors; Voriconazole	2022
Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study. BMC neurology, 2022, Jul-22, Volume: 22, Issue:1 Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Hypokalemia; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome; Voriconazole	2022
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China. BMC infectious diseases, 2022, Aug-08, Volume: 22, Issue:1 Topics: Amphotericin B; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Infertility; Meningitis, Cryptococcal; Prospective Studies; Voriconazole	2022